In the LiteratureShedding New Light on an Old Dilemma: Two Trials Examining the Timing of Renal Replacement Therapy Initiation in Acute Kidney Injury
Section snippets
What Do These Important Studies Show?
The AKIKI trial was an open-label 31-center trial in France that tested the hypothesis that a delayed strategy of RRT initiation would lead to an absolute 15% improvement in 60-day survival among critically ill patients with severe AKI.14 The investigators recruited 620 critically ill adults with KDIGO (Kidney Disease: Improving Global Outcomes) stage 3 AKI attributed to acute tubular necrosis who were being treated with either mechanical ventilation or vasopressors. They excluded patients with
How Do These Studies Compare With Prior Studies?
AKIKI and ELAIN were well-executed trials that represent important additions to our understanding of optimal triggers and circumstances for RRT initiation in AKI. By virtue of being randomized controlled trials, these were free of the biases inherent to the observational studies that have previously dominated this field. The only other randomized trials in this area were a significantly underpowered study to detect meaningful differences in patient outcomes9 and a small pilot trial that our
What Should Clinicians and Researchers Do?
The publication of 2 similarly themed trials with conflicting results will likely sustain the clinical uncertainty regarding the optimal timing of RRT initiation in AKI. The cautious clinician should avoid the temptation to embrace the trial that validates his or her current practice or cognitive biases regarding the optimal time of RRT initiation. Though both are nominally regarded as “timing trials,” AKIKI and ELAIN had fundamental differences in philosophy and design (Table 1).
The key
Acknowledgements
Support: The authors are supported by research funding from the Canadian Institute of Health Research (MOP-142296) and an unrestricted research grant provided by Baxter (IPR-139081).
Financial Disclosure: The authors are steering committee members of the ongoing STandard vs Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial (Clinicaltrials.gov NCT02568722). Drs Wald and Bagshaw have served as paid consultants and speakers for Baxter. Dr Bagshaw is the
References (23)
- et al.
Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: a population-based cohort study
Am J Kidney Dis
(2015) - et al.
Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial
Lancet
(2006) - et al.
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients
Kidney Int
(2005) - et al.
Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis
Am J Kidney Dis
(2008) - et al.
Earlier-start versus usual-start dialysis in patients with community-acquired acute kidney injury: a randomized controlled trial
Am J Kidney Dis
(2013) - et al.
Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury
Kidney Int
(2015) - et al.
Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia
Kidney Int
(2011) - et al.
Temporal changes in incidence of dialysis-requiring AKI
J Am Soc Nephrol
(2013) - et al.
Intensity of renal support in critically ill patients with acute kidney injury
N Engl J Med
(2008) - et al.
Intensity of continuous renal-replacement therapy in critically ill patients
N Engl J Med
(2009)
A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis
Crit Care
Cited by (8)
Why ELAIN and AKIKI Should Not Be Compared: Resolving Discordant Studies
2017, American Journal of Kidney DiseasesIn Reply to ‘Why ELAIN and AKIKI Should Not Be Compared: Resolving Discordant Studies’
2017, American Journal of Kidney DiseasesTiming of initiation of renal-replacement therapy in acute kidney injury
2020, New England Journal of MedicineNoteworthy Literature published in 2017 for Cardiac Critical Care
2018, Seminars in Cardiothoracic and Vascular AnesthesiaRenal replacement therapy: Timing of initiation and intradialytic hypotension
2017, American Journal of Respiratory and Critical Care Medicine